The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1
about
Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virusCrystal structures of the X-domains of a Group-1 and a Group-3 coronavirus reveal that ADP-ribose-binding may not be a conserved propertyMolecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationTargeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsHelicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular healthHIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionHIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series.Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanismHIV-1 Vpr: mechanisms of G2 arrest and apoptosis.Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NF-kappa B activation pathway.TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?The Sound of Silence: RNAi in Poly (ADP-Ribose) ResearchCell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases.Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus EntryPrimate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy.Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection.H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancerIn Silico Investigation of a HIV-1 Vpr Inhibitor Binding Site: Potential for Virtual Screening and anti-HIV Drug Design.Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB.T-Cell Signaling in HIV-1 Infection.Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells
P2860
Q24669960-99F2BB71-AE36-458C-AB8A-67915D38605CQ27487330-CE665FB6-E360-4997-81FB-DDA44A8DE704Q27653582-CA4700D2-3EAA-4E55-9322-7B430EDF7EDEQ28236770-81087CB0-AAF8-4BC6-8C63-CBB977067753Q33613493-710575A4-B020-4BE9-B6AB-FCD11B05766AQ34664112-AC8C8568-CFEA-4225-8A07-A13F17B6B4AFQ34957142-953FCA55-A3B3-4B16-83AD-6FF3D941A8BDQ35399263-BDC16C32-8978-4702-8097-1C8DB01AD654Q35581323-70389EF3-B9C9-438B-A212-88FC3AD95866Q35826774-342A187A-4D0B-4A80-AE55-6CFD0D866646Q36706005-AB8DA239-BE28-466C-8447-635E0FA57BBEQ36969275-6DF3FA71-04DF-43D4-B502-8123D3C88F0DQ36974683-B13E6FDF-7B92-4D39-B4CD-94431494A36CQ37029922-08DD7E89-E223-498D-A3AA-752D8E062AADQ37087622-AF889D3D-7619-4E3F-8946-A0D1FF24BB99Q37433321-5FD46C5F-AD2B-4B70-99CE-9050B57CA51CQ37508170-3047930F-5F03-4D43-8742-FD19A0A2AF41Q37638957-A8B3567C-71AC-4490-9072-321BEBACB896Q38849121-6BF371F5-301F-41CB-AF60-AFDDB6A3CC52Q40062891-EF88745B-E700-4294-AF5C-715D9983121BQ40458807-F84E7434-DDC0-468D-87A3-B50C29EEF13FQ40623679-E29C322F-C8AE-4272-AA25-D8AD9C37264BQ41309782-37915604-89CA-4D84-892A-89DA2410A4A8Q41643903-B0034F77-1B9A-48BA-A573-A2A5EE4AB72CQ42001077-D319FBF6-2D0B-400E-BFB6-2B714421D933Q42273481-9F71C3DE-ED63-49F2-AAC1-603F1525D5A6Q57081527-633D6E62-7263-42D0-AF6E-C7C09B2D4D34
P2860
The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@ast
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@en
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@nl
type
label
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@ast
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@en
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@nl
prefLabel
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@ast
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@en
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@nl
P2093
P2860
P3181
P356
P1433
P1476
The HIV-1 Vpr and glucocortico ...... nuclear localization of PARP-1
@en
P2093
Andrew Y Choo
Arumugam Premkumar
Craig B Thompson
Daniel S Hwang
David B Weiner
Joann Emmanuel
Khanh P Thieu
Muniswamy Madesh
Sanjeev Kumar
Wei-Xing Zong
P2860
P2888
P304
P3181
P356
10.1038/NCB1352
P407
P577
2006-01-22T00:00:00Z
P5875
P6179
1046910421